Isomorphic Labs

AI-driven drug discovery company founded by Nobel laureate Sir Demis Hassabis, spun out of Google DeepMind and Alphabet. Building on and beyond the AlphaFold system, Isomorphic Labs develops predictive and generative AI models to accelerate drug design at digital speed. Partners include Eli Lilly, Novartis, and Johnson & Johnson.